Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies

  • 1Email author,
  • 1, 2,
  • 1,
  • 1,
  • 3,
  • 2,
  • 1, 4,
  • 1,
  • 1, 5,
  • 1, 5,
  • 1,
  • 1 and
  • 1, 6
Virology Journal201916:12

https://doi.org/10.1186/s12985-019-1118-8

  • Received: 4 January 2019
  • Accepted: 8 January 2019
  • Published:

The original article was published in Virology Journal 2018 15:192

Correction to: Virol J

https://doi.org/10.1186/s12985-018-1105-5

In the original publication of this article [1], Table 1 has some errors. The correct one is below:
Table 1

Comparison of VNT and PRNT assays for a panel of 142 samples

VNT

PRNT50

PRNT90

Positive (titre ≥10)

Negative (titre < 10)

Positive (titre ≥10)

Negative (titre < 10)

Positive (titre ≥40)

51

1

51

1

Negative (titre < 40)

9

81

1

89

Sensitivity of VNT

(95% CI)

85% (51/60)

(72.9–92.4%)

98.8% (51/52)

(88.4–99.9%)

Specificity of VNT

(95% CI)

98.7% (81/82)

(92.4–99.9%)

98.8% (89/90)

(93.1–99.9%)

The publisher apologizes to the readers and authors for the inconvenience.

The original publication has been corrected.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Unité des Virus Émergents (UVE: Aix-Marseille Univ – IRD 190 – Inserm 1207– IHU Méditerranée Infection), Marseille, France
(2)
Virología II, Centro Nacional de Enfermedades Tropicales (CENETROP), Santa Cruz de la Sierra, Bolivia
(3)
Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany
(4)
Centre Pasteur du Cameroun, Yaoundé, Cameroon
(5)
National Reference Centre for Arboviruses, French Armed Forces Biomedical Research Institute, Marseille, France
(6)
Laboratoire de Virologie, Établissement Français du Sang Alpes Méditerranée (EFS), Marseille, France

Reference

  1. Nurtop, et al. Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies. Virol J. 2018;15:192. https://doi.org/10.1186/s12985-018-1105-5.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2019

Advertisement